Foundayo (Orforglipron) : A novel oral GLP-1 option offering flexible dosing without food restraints for ultimate convenience
Product Details Active Ingredients: Loperamide HCl 2 mg (per caplet) - Anti-diarrheal Simethicone 125 mg (per caplet) - Anti-gas Inactive Ingredients: Acesulfame potassium, croscarmellose sodium, dibasic calcium phosphate, flavor, microcrystalline cellulose, stearic acid Relieves symptoms of diarrhea plus bloating, pressure, and cramps, commonly referred to as gas
What the Phase 2 Trial Data Shows VK2735 Subcutaneous VENTURE Trial (13 Weeks) The Phase 2 VENTURE trial was short only 13 weeks but the results were striking
56 NavabpourS.MorrisK.AllenR.HarrisonE.A-H-MackernessS.Buchanan-WollastonV
Research Findings The research foundation for Epithalon is substantial, though much of this work has been conducted in Russia and published primarily in Russian or Eastern European journals, with less representation in mainstream Western scientific literature